Flexion Therapeutics, Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating loss was USD 16.882 million compared to USD 27.267 million a year ago. Net loss was USD 22.208 million compared to USD 32.619 million a year ago. Basic loss per share from continuing operations was USD 0.44 compared to USD 0.76 a year ago. For the half year, operating loss was USD 40.023 million compared to USD 59.849 million a year ago. Net loss was USD 50.764 million compared to USD 69.421 million a year ago. Basic loss per share from continuing operations was USD 1.02 compared to USD 1.71 a year ago.